TABLE I.

Proportion of patients on epoetin alfa (epo) transfused during chemotherapy

Chemotherapy regimen	Patients transfused (%)
	On study		During months 2 and 3
	epo	Placebo	epo	Placebo
Without cisplatin	44	44	21	33
With cisplatin	50	63	23 p < 0.05	56
Combined	47	53	22 p < 0.05	43